Ogenix is the manufacturer of EPIFLO, an FDA cleared, 3 ounce, 24/7 oxygen therapy which effectively treats many chronic wounds such as diabetic foot ulcers, venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns and other non-healing wounds.
| Website | http://www.ogenix.com |
| Revenue | $5 million |
| Employees | 7 (2 on RocketReach) |
| Founded | 1995 |
| Address | 3401 Enterprise Pkwy Ste 340, Beachwood, Ohio 44122, US |
| Phone | +1 856-468-5000 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Web Rank | 4 Million |
| Keywords | Fda Cleared, Oxygen Therapy, Wound Care, Chronic Wound Treatment, Portable Oxygen, Diabetic Foot Ulcer Treatment, Home Oxygen Therapy, Medical Oxygen, Pressure Sore Treatment, Wound Healing, Surgical Wound Care, Burn Treatment, Non Healing Wounds, Advanced Wound Care, Medical Devices |
| Competitors | Roche, Novartis, Pfizer, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Biogen, Lilly India +41 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Ogenix employee's phone or email?
The Ogenix annual revenue was $5 million in 2026.
Gregory Calvitt is the CEO of Ogenix.
2 people are employed at Ogenix.
Ogenix is based in Beachwood, Ohio.
The NAICS codes for Ogenix are [334, 33].
The SIC codes for Ogenix are [384, 38].